Once-daily aminoglycoside therapy: potential ototoxicity.
AUTOR(ES)
Singer, C
RESUMO
Current data indicate that once-daily aminoglycoside therapy is as efficacious as traditional multiple daily dosing and equally or less toxic. Our experience with once-daily gentamicin, 6 mg/kg of body weight led to a 10% (3 of 33 patients) occurrence of documented ototoxicity after prolonged aminoglycoside exposure.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163502Documentos Relacionados
- Once-daily aminoglycoside therapy: potential ototoxicity.
- Once-daily aminoglycoside therapy.
- Once-daily gentamicin therapy for experimental Escherichia coli meningitis.
- Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
- Once-daily ceftriaxone therapy for serious bacterial infections in children.
